Skip to content
ClinCalc Pro
Menu
Antibiotic — Tonsillitis / Pharyngitis Pregnancy: There are no or a limited amount of data from use in pregnant women; as a precautionary measure it is preferable to avoid use during pregnancy. Metabolites are excreted in human milk to such an extent that effects on breastfed newborns are likely (§4.6).

Phenoxymethylpenicillin (Penicillin V)

Brand names: Penicillin VK

Phenoxymethylpenicillin (penicillin V) is a narrow-spectrum oral penicillin used for streptococcal infections such as tonsillitis, and for prophylaxis (e.g. asplenia, rheumatic fever).

Auto-extracted from the source labelling — not yet independently clinician-verified. These values were distilled from the UK SPC (or the US label where noted) but have not had a clinician sign-off. Confirm against the current SmPC before prescribing.

Adult dose

Dose: 250 mg to 500 mg
Route: Oral
Frequency: Every 6 hours
Adults (including the elderly) and children over 12 years: 250 mg to 500 mg every six hours. The dosage and frequency depend on the severity and localisation of the infection and the expected pathogens. For oral administration only; take at least 30 minutes before or 2 hours after food, as ingestion with meals slightly reduces absorption. 250 mg is approximately equivalent to 400,000 units. PROPHYLACTIC USE: prophylaxis of rheumatic fever/chorea — 250 mg twice daily on a continuing basis; prophylaxis of pneumococcal infection (e.g. in asplenia and in sickle cell disease) — adults and children over 12 years 500 mg every 12 hours, children 6-12 years 250 mg every 12 hours, children below 5 years 125 mg every 12 hours. Streptococcal infections should be treated for a minimum of 10 days, with post-therapy cultures to confirm eradication (§4.4). Elderly: dosage is as for adults. Hepatic impairment: dosage adjustment may be necessary in patients with impaired liver function when they also have renal failure, as the liver may then be a major excretion route. Oral therapy should not be relied upon in patients with severe illness, or with nausea, vomiting, gastric dilation, achalasia or intestinal hypermotility. Paediatric doses in the SPC are given by age band rather than per kg (infants up to 1 year 62.5 mg every 6 hours; 1-5 years 125 mg every 6 hours; 6-12 years 250 mg every 6 hours), so no mg/kg dose is expressed here — verify any under-18 use against a children's formulary. The source product is an oral solution (125 mg/5 ml powder for oral solution) containing sucrose — not for patients with rare hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.

Dose adjustments

Renal

The dosage should be reduced if renal function is markedly impaired; administer with caution in the presence of markedly impaired renal function, as the safe dosage may be lower than the usually recommended doses.

Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.

US labelling (FDA)

Reference — US labelling, may differ from UK

DOSAGE AND ADMINISTRATION The dosage of Penicillin V should be determined according to the sensitivity of the causative microorganisms and the severity of infection, and adjusted to the clinical response of the patient. The usual dosage recommendations for adults and children 12 years and over are as follows: Streptococcal Infections Mild to moderately severe - of the upper respiratory tract and including scarlet fever and erysipelas: 125 to 250 mg (200,000 to 400,000 units) every 6 to 8 hours for 10 days. Pneumococcal Infections Mild to moderately severe - of the respiratory tract, including otitis media: 250 to 500 mg (400,000 to 800,000 units) every 6 hours until the patient has been …

Source: US FDA prescribing information (openFDA / DailyMed), label dated 2025-10-15. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.

Contraindications

  • Hypersensitivity to penicillin or to any of the excipients
  • Use with caution in patients with known histories of allergy

Side effects

  • Nausea, vomiting, abdominal pain, diarrhoea (common)
  • Allergic reactions typically manifesting as urticarial, erythematous or morbilliform rash and pruritus (common)
  • Severe allergic reactions causing angioedema, laryngeal oedema and anaphylaxis (rare); serum sickness-like reactions with fever, chills, arthralgia and oedema (frequency unknown)
  • Changes in blood counts including thrombocytopenia, neutropenia, leucopenia, eosinophilia and haemolytic anaemia (very rare)
  • Pseudomembranous colitis (frequency unknown); CNS toxicity including convulsions, especially with high doses or in severe renal impairment

Interactions

  • Neomycin (aminoglycoside): reported to reduce absorption of phenoxymethylpenicillin
  • Anticoagulants: penicillins may interfere with anticoagulant control
  • Bacteriostatic antibiotics (chloramphenicol, erythromycin, tetracyclines): reported to antagonise the bactericidal activity of penicillins - concomitant use not recommended
  • Guar gum: reduced absorption of phenoxymethylpenicillin
  • Methotrexate: reduced methotrexate excretion, increasing the risk of toxicity
  • Probenecid and sulfinpyrazone: reduced excretion of phenoxymethylpenicillin (competition for renal tubular secretion)
  • Oral typhoid vaccine: may be inactivated by penicillins if ingested concomitantly

Clinical monograph

How it works

A beta-lactam that inhibits bacterial cell-wall synthesis.

Prescribing in practice

  • Contraindicated in penicillin allergy.
  • Take it on an empty stomach (before food) for better absorption.
  • For sore throat, target antibiotics using clinical scores (e.g. FeverPAIN/Centor) per guidance.

Monitoring

Short courses need no routine monitoring.

Counselling the patient

  • Take it before food and complete the course.
  • Report a rash or other signs of allergy.

Evidence & guidelines

First-line for group A streptococcal throat infection and certain prophylaxis indications per NICE/PHE guidance.

Reference: NICE NG84 (Sore Throat — Antibiotic Prescribing 2018); SIGN 117; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.